Littérature scientifique sur le sujet « HSOD1 »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « HSOD1 ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "HSOD1"
Bouldin, Samantha D., Maxwell A. Darch, P. John Hart et Caryn E. Outten. « Redox properties of the disulfide bond of human Cu,Zn superoxide dismutase and the effects of human glutaredoxin 1 ». Biochemical Journal 446, no 1 (27 juillet 2012) : 59–67. http://dx.doi.org/10.1042/bj20120075.
Texte intégralCoelho, Fernando R., Asif Iqbal, Edlaine Linares, Daniel F. Silva, Filipe S. Lima, Iolanda M. Cuccovia et Ohara Augusto. « Oxidation of the Tryptophan 32 Residue of Human Superoxide Dismutase 1 Caused by Its Bicarbonate-dependent Peroxidase Activity Triggers the Non-amyloid Aggregation of the Enzyme ». Journal of Biological Chemistry 289, no 44 (18 septembre 2014) : 30690–701. http://dx.doi.org/10.1074/jbc.m114.586370.
Texte intégralZhang, Kun, Yuejuan Zhang, Jing Zi, Xiaochang Xue et Yi Wan. « Production of Human Cu,Zn SOD with Higher Activity and Lower Toxicity inE. colivia Mutation of Free Cysteine Residues ». BioMed Research International 2017 (2017) : 1–12. http://dx.doi.org/10.1155/2017/4817376.
Texte intégralÁlvarez-Zaldiernas, Cristina, Jun Lu, Yujuan Zheng, Hongqian Yang, Juan Blasi, Carles Solsona et Arne Holmgren. « Cellular Redox Systems Impact the Aggregation of Cu,Zn Superoxide Dismutase Linked to Familial Amyotrophic Lateral Sclerosis ». Journal of Biological Chemistry 291, no 33 (3 juin 2016) : 17197–208. http://dx.doi.org/10.1074/jbc.m115.708230.
Texte intégralFENG, LIN, Yan Dan Dan, Chen Ya Wen, Fletcher Emmanuella E, Shi Hai Feng, Han Bang Xing et Zhou Yang. « Cloning, purification and enzymatic characterization of recombinant human Superoxide dismutase 1 expressed in Escherichia coli ». Acta Biochimica Polonica 65, no 2 (8 juillet 2018) : 235–40. http://dx.doi.org/10.18388/abp.2017_2350.
Texte intégralIslam, Rafique, Emily L. Kumimoto, Hong Bao et Bing Zhang. « ALS-linked SOD1 in glial cells enhances ß-N-Methylamino L-Alanine (BMAA)-induced toxicity in Drosophila ». F1000Research 1 (9 novembre 2012) : 47. http://dx.doi.org/10.12688/f1000research.1-47.v1.
Texte intégralMartin, Lee J., Danya A. Adams, Mark V. Niedzwiecki et Margaret Wong. « Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS : Targeting DNA Methylation Is Therapeutic ». Cells 11, no 21 (31 octobre 2022) : 3448. http://dx.doi.org/10.3390/cells11213448.
Texte intégralSelf, Wade K., Kathleen Schoch, James Bollinger, Tracy Cole, Holly Kordasiewicz, Randall Bateman et Timothy Miller. « 2342 Protein production as an early pharmacodynamics biomarker for RNA-targeting therapies ». Journal of Clinical and Translational Science 2, S1 (juin 2018) : 24. http://dx.doi.org/10.1017/cts.2018.110.
Texte intégralBrasil, Aline de Araújo, Mariana Dias Castela de Carvalho, Ellen Gerhardt, Daniela Dias Queiroz, Marcos Dias Pereira, Tiago Fleming Outeiro et Elis Cristina Araujo Eleutherio. « Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1 ». Proceedings of the National Academy of Sciences 116, no 51 (3 décembre 2019) : 25991–6000. http://dx.doi.org/10.1073/pnas.1902483116.
Texte intégralQueiroz, Raphael F., Verônica Paviani, Fernando R. Coelho, Emerson F. Marques, Paolo Di Mascio et Ohara Augusto. « The carbonylation and covalent dimerization of human superoxide dismutase 1 caused by its bicarbonate-dependent peroxidase activity is inhibited by the radical scavenger tempol ». Biochemical Journal 455, no 1 (13 septembre 2013) : 37–46. http://dx.doi.org/10.1042/bj20130180.
Texte intégralThèses sur le sujet "HSOD1"
Thyssen, Stella [Verfasser], Jochen [Akademischer Betreuer] Weishaupt et Oliver [Akademischer Betreuer] Wirths. « Einfluss des Proteinaggregationshemmstoffs anle138b auf Beginn und Verlauf der Amyotrophen Lateralsklerose im transgenen hSOD1-Mausmodell / Stella Thyssen. Gutachter : Jochen Weishaupt ; Oliver Wirths. Betreuer : Jochen Weishaupt ». Göttingen : Niedersächsische Staats- und Universitätsbibliothek Göttingen, 2014. http://d-nb.info/1053119283/34.
Texte intégralWhite, Christopher Iain. « Cardiovascular 11β-HSD1 : its role in myocardial physiology and pathophysiology ». Thesis, University of Edinburgh, 2016. http://hdl.handle.net/1842/23391.
Texte intégralLeiva, Martínez Rosana. « Polycyclic group optimization in 11β-HSD1 inhibitors and their pharmacological evaluation ». Doctoral thesis, Universitat de Barcelona, 2017. http://hdl.handle.net/10803/457770.
Texte intégralAndres, Janin. « Untersuchungen über Regulationsmechanismen der 11beta-Hydroxysteroid Dehydrogenase Typ 1 ». Phd thesis, Universität Potsdam, 2008. http://opus.kobv.de/ubp/volltexte/2009/3303/.
Texte intégralThe enzyme 11beta-HSD1 regulates intracellular the cortisol concentration by regeneration of cortisone to cortisol. Hence, 11beta-HSD1 is an important factor in glucocorticoid-mediated gene expression. It is ubiquitously expressed, but high levels have been specifically described in liver, adipose tissue and smooth muscle cells. A pivotal role for 11beta-HSD1 has been demonstrated with respect to metabolism in liver and adipose tissue. Thus, a liver-specific overexpression results in an elevated gluconeogenesis and hepatic glucose output. Furthermore, a fat-specific overexpression was associated with obesity, insulin resistance and dyslipidemia. Despite these intriguing data, the regulation of the human 11beta-HSD1 gene is still in its infancies. 8 promoter fragments from -3034 to +188 of 11beta-HSD1-gene were cloned to analyze promoter activity. Dual-Luciferase-Assay was used in humane HepG2 cells and in undifferentiated and differentiated 3T3-L1 cells. Furthermore, the region close to the transcription start was studied with a non-radioactive EMSA for binding of TATA-binding protein (TBP) and CCAAT/enhancer-binding-protein (C/EBP). The role of the endogenous and exogenous regulators fatty acids, PPARgamma and the incretin (Glucose-dependent insulinotropic Peptide) GIP was investigated in-vitro and in-vivo. Finally, the functional consequences of 2 Single Nucleotide Polymorphisms (SNP) within the promoter region were studied in cell culture and the MeSyBePo-cohorts for association with diabetes mellitus type 2 and body weight. The Luciferase-assay revealed a cell-specific regulation of 11beta-HSD1 and a repressor, which was active in all 3 cell models. Accordingly, a cell-specific regulation was observed in transactivation-assays with C/EBP-proteins -alpha, -beta and -delta. The 11beta-HSD1 enzyme expression and activity was specifically modified by the here investigated endogenous and exogenous factors, which was demonstrated in-vitro but also in-vivo in various experimental settings. The characterisation of the MeSyBePo-cohorte revealed no association between genotype and clinical phenotype, although a trend for an increased body weight and diabetes mellitus type 2 was detected. This work demonstrated a cell-specific regulation of the 11beta-HSD1 promoter. Furthermore, a binding site for TATA-binding proteins was detected in HepG2 and undifferentiated 3T3-L1 cells. A pivotal role in regulation of 11beta-HSD1 promoter activity was demonstrated for the C/EBP-proteins, especially in liver cells. The in-vivo-Studies revealed a regulation of enzyme expression and activity by endogenous, exogenous and pharmacological substances, which was confirmed and analyzed in more detail in cell culture experiments.
Zhang, Zhenguang. « Role of macrophage 11β-HSD1 in inflammation mediated angiogenesis, arthritis and obesity ». Thesis, University of Edinburgh, 2014. http://hdl.handle.net/1842/9553.
Texte intégralWamil, Małgorzata. « Protective role of 11β-HSD1 inhibition in the metabolic syndrome and atherosclerosis ». Thesis, University of Edinburgh, 2009. http://hdl.handle.net/1842/3891.
Texte intégralCoutinho, Agnes Elizabeth. « Consequences of 11β-hydroxysteroid dehydrogenase deficiency during inflammatory responses ». Thesis, University of Edinburgh, 2009. http://hdl.handle.net/1842/4190.
Texte intégralVerma, Manu. « Deficiency of 11β-HSD1 modulates energy homeostasis in the brain following systemic inflammation ». Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/33323.
Texte intégralLiu, Xiaoxia. « Regulation and function of 11β-hydroxysteroid dehydrogenase (11β-HSD1) in pancreatic β-cells ». Thesis, University of Edinburgh, 2011. http://hdl.handle.net/1842/5582.
Texte intégralMitić, Tijana. « Role of murine 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) in the metabolism of 7-oxysterols ». Thesis, University of Edinburgh, 2010. http://hdl.handle.net/1842/4416.
Texte intégralChapitres de livres sur le sujet "HSOD1"
Colas, D., J. London, R. Cespuglio et N. Sarda. « Polysomnography in transgenic hSOD1 mice as Down syndrome model ». Dans Advances in Down Syndrome Research, 165–71. Vienna : Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-6721-2_15.
Texte intégralScott*, James S., et Jasen Chooramun. « Chapter 5. 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors in Development ». Dans Drug Discovery, 109–41. Cambridge : Royal Society of Chemistry, 2012. http://dx.doi.org/10.1039/9781849735322-00109.
Texte intégralPaderes, Genevieve D., Klaus Dress, Buwen Huang, Jeff Elleraas, Paul A. Rejto et Tom Pauly. « Structure-Based and Property-Compliant Library Design of 11β-HSD1 Adamantyl Amide Inhibitors ». Dans Methods in Molecular Biology, 191–215. Totowa, NJ : Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-931-4_10.
Texte intégralReynolds, Rebecca M., et Scott P. Webster. « Translational Research in Stress Neuroendocrinology : 11β-Hydroxysteroid Dehydrogenase 1 (11β-HSD1), A Case Study ». Dans Neuroendocrinology of Stress, 327–50. Chichester, UK : John Wiley & Sons, Ltd, 2015. http://dx.doi.org/10.1002/9781118921692.ch14.
Texte intégralNaredo-Gonzalez, G., MA Jansen, GD Merrifield, OB Sutcliffe, MK Hansen, R. Andrew et BR Walker. « Non-Invasive In-Vivo Monitoring of 11β-HSD1 Activity Using19F-Magnetic Resonance Spectroscopy. » Dans Posters I, P3–32—P3–32. Endocrine Society, 2010. http://dx.doi.org/10.1210/endo-meetings.2010.part3.p1.p3-32.
Texte intégralTiganescu, A., AE Mayes, R. Hardy, PM Stewart et EA Walker. « Is Increased 11β-HSD1 Expression a Key Factor Underpinning Intrinsic and Extrinsic Skin Aging?. » Dans Posters I, P3–31—P3–31. Endocrine Society, 2010. http://dx.doi.org/10.1210/endo-meetings.2010.part3.p1.p3-31.
Texte intégralKienitz, T., M. Michaelis, P. Hofmann, F. Gotz et M. Quinkler. « Regulation of 11beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Expression in the Rat Heart by Androgens. » Dans Posters I, P3–34—P3–34. Endocrine Society, 2010. http://dx.doi.org/10.1210/endo-meetings.2010.part3.p1.p3-34.
Texte intégralLatif, Syed A., Renshan Ge et David J. Morris. « Differential Inhibition of 11β-HSD1 Dehydrogenase by 5β-Ring-a-Reduced Metabolites of 11-Desoxy-Steroid Hormones ». Dans BASIC/TRANSLATIONAL - Steroidogenesis & ; Its Disorders, P2–592—P2–592. The Endocrine Society, 2011. http://dx.doi.org/10.1210/endo-meetings.2011.part3.p8.p2-592.
Texte intégralLavery, Gareth G., Laura L. Gathercole, Stuart A. Morgan, Agnieszka Zielinska, Khalid Saqib, Beverley Hughes, Elizabeth A. Walker et Paul M. Stewart. « Lack of a Beneficial Metabolic Profile in Liver-Specific 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Knockout Mice ». Dans BASIC/TRANSLATIONAL - Molecular Mechanisms Regulating Glucose Homeostasis & ; Insulin Action, OR23–4—OR23–4. The Endocrine Society, 2011. http://dx.doi.org/10.1210/endo-meetings.2011.part3.or4.or23-4.
Texte intégralEsteves, CL, V. Kelly, T.-M. Man, JR Seckl et KE Chapman. « Dietary Regulation of 11β-HSD1 in Adipose Tissue Is Mediated by the C/EBPβ Isoforms LAP and LIP. » Dans The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego, OR19–5—OR19–5. Endocrine Society, 2010. http://dx.doi.org/10.1210/endo-meetings.2010.part3.or1.or19-5.
Texte intégralActes de conférences sur le sujet "HSOD1"
Finke, U., J. Schneider, E. Friderichs, L. Flohé et H. Giertz. « MYOCARDIAL SALVAGE BY COMBINED TREATMENT WITH RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN ACTIVATOR AND RECOMBINANT HUMAN SUPEROXIDE DISMUTASE IN A CANINE CORONARY THROMBOSIS MODEL* ». Dans XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643570.
Texte intégralVitiello, M., V. Kunnathully, G. Orsolini, O. Viapiana, F. Poli, A. Mattè, L. De Franceschi, L. Idolazzi, D. Gatti et M. Rossini. « AB0045 Il-17 induced glucocorticoid insensitivity might be dependent on the reduced 11beta-hsd1 enzyme activity ». Dans Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.2681.
Texte intégralGrumbach, Y., A. Hu, JS Grunstein, G. Nino, L. Gober et MM Grunstein. « Regulation of 11ß-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Expression in Human Airway Smooth Muscle (HASM) Cells. » Dans American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a6313.
Texte intégralNikmaturrohana, Qurin, Sri Rahayu Lestari et Betty Lukiati. « Potential of single bulb garlic (Allium sativum) active compound as an 11β-HSD1 inhibitor in obesity through in silico method ». Dans PROCEEDINGS OF THE 3RD INTERNATIONAL SEMINAR ON METALLURGY AND MATERIALS (ISMM2019) : Exploring New Innovation in Metallurgy and Materials. AIP Publishing, 2020. http://dx.doi.org/10.1063/5.0002532.
Texte intégral